The potential role of morus alba leaves extract on the brain of mice infected with schistosoma mansoni

CNS and Neurological Disorders - Drug Targets

Volumn 13, Issue 9, 2014, Pages 1513-1519

  Bauomy, Amira A ^a  

^a HELWAN UNIVERSITY   (Egypt)

Author keywords

Biochemical; Brain; Histopathology; Mice; Morus alba; Schistosoma mansoni

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINESTERASE; ALCOHOL; CATALASE; CHLORIDE ION; GLUTATHIONE; MALONALDEHYDE; MULBERRY EXTRACT; NITRATE; NITRITE; PRAZIQUANTEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ASSAY; ARTICLE; BRAIN HOMOGENATE; BRAIN TISSUE; CONTROLLED STUDY; HISTOPATHOLOGY; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PLANT LEAF; SCHISTOSOMIASIS MANSONI;

EID: 84920566265     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527313666140806120717     Document Type: Article

References (56)

1. WHO. Tropical Disease Research (TDR). 2013; Accessed from http://www.who.int/tdr/en/
2. Braga MHV, de Carvalho GTC, Brandão RACS. Pseudotumoral form of cerebral Schistosomiasis mansoni. World Neurosurg 2011; 76(1-2): 200-7.
3. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006; 6: 411-25.
4. Berriman M, Haas BJ, LoVerde PT, et al. The genome of the blood fluke Schistosoma mansoni. Nature 2009; 460: 352-8.
5. de Oliveira RB, Senger MR, Vasques LM, et al. Schistosoma mansoni infection causes oxidative stress and alters receptor for advanced glycation endproduct (RAGE) and tau levels in multiple organs in mice. Int J Parasitol 2013; 43(5): 371-9.
6. Pittella JE, Lana-Peixoto MA. Brain involvement in hepatosplenic Schistosomiasis mansoni. Brain 1981; 104(3): 621-32.
7. Preidler KW, Riepl T, Szolar D, Ranner G. Cerebral schistosomiasis: MR and CT appearance. Am J Neuroradiol 1996; 17(8): 1598-600.
8. Haribhai HC, Bhigjee AI, Bill PLA, et al. Spinal cord schistosomiasis. Brain 1991; 114: 709-26.
9. Fiore M, Alleva E, Moroni R, Aloe L. Infection with Schistosoma mansoni in Mice Induces Changes in Nociception and Exploratory Behavior. Physiol Behavior 1998; 65(2): 347-53.
10. Yousif F, Hifnawy MS, Soliman G. Large-scale in vitro screening of Egyptian native and cultivated plants for schistosomicidal activity. Pharm Biol 2007; 45: 501-10.
11. Agarwal S, Kanwar K. Comparison of genetic transformation in Morus alba L. via different regeneration systems. Plant Cell Rep 2007; 26(2): 177-85.
12. Chen F, Nakashima N, Kimura I, et al. Potentiating effects on pilocarpine-induced saliva secretion, by extracts and N-containing sugars derived from mulberry leaves, in streptozocin-diabetic mice. Biol Pharmaceut Bull 1995; 18: 1676-80.
13. Butt MS, Nazir A, Tauseef MS, Schroën K. Morus alba L. nature’s functional tonic. Trends Food Sci Technol 2008; 19: 505-12.
14. Volpato GT, Calderon IMP, Sinzato S, et al. Effect of Morus nigra aqueous extract treatment on the maternal–fetal outcome, oxidative stress status and lipid profile of streptozotocin-induced diabetic rats. J Ethnopharmacol 2011; 138: 691-6.
15. Nomura T. The chemistry and biosynthesis of isoprenylated flavonoids from moraceous plants. Pure Appl Chem 1999; 71: 1115-8.
16. Yadav AV, Kawale LA, Nade VS. Effect of Morus alba L. (mulberry) leaves on anxiety in mice. Ind J Pharmacol 2008; 40(1): 32-6.
17. Oh H, Ko EK, Jun JY, et al. Hepatoprotective and radical scavenging activities of preflavonoids, Coumarin and stilbene from Morus alba. Plant Med 2002; 68: 932-4.
18. Kang TH, Oh HR, Jung SM, et al. Enhancement of Neuroprotection of Mulberry leaves (Morus alba L.) prepared by the Anaerobic treatment against ischemic damage. Biol Pharm Bull 2006; 29: 270-4.
19. Fallon PG, Doenhoff MJ. School of Biological Sciences, University of Wales, Bangor, Gwynedd, United Kingdom. Am J Trop Med Hyg 1994; 51(1): 83-8.
20. Dufour V, Beech RN, Wever C, Dent JA, Geary TG. Molecular Cloning and Characterization of Novel Glutamate-Gated Chloride Channel Subunits from Schistosoma mansoni. PLoS Pathog 2013; 9(8): 1003586.
21. Oliver L, Stirewalt MA. An efficient method for the exposure of mice to cercaria of Schistosoma mansoni. J Parasitol 1952; 38: 19- 23.
22. +-ATPase activities induced by the in vitro galactosaemia. Pharmacol Res 2004; 49: 475-9.
23. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-7.
24. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001; 54: 356-61.
25. Aebi H. Catalase in vitro. In: Methods Enzymology 105. Academic Press 1984; pp. 121-6.
26. Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-8.
27. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
28. Sutton I, Simmonds MA. Effects of acute and chronic pentobarbital on the γ-aminobutyric acid system in rat brain. Biochem Pharmacol 1974; 23: 1801-8.
29. Murphy VA. Method for determination of sodium, potassium, calcium, magnesium, chloride and phosphate in the rat choroid plexus by flame atomic absorption and visible spectroscopy. Anal Biochem 1987; 161: 144-51.
30. Gorun V, Proinov I, Băltescu V, Balaban G, Bârzu O. Modified Ellman procedure for assay of cholinesterases in crude enzymatic preparations. Anal Biochem 1978; 86: 324-6.
31. Aloe L, Fiore M. Neuroinflammatory Implications of Schistosoma mansoni Infection: New Information from the Mouse Model. Parasitol Today 1998; 14(8): 314-8.
32. Farrag E, Maghraby A, Foda DS. Chemop rophylactic effect of selenium and vitamin E against Schistosoma mansoni infected mice. Egypt Pharm J 2005; 4: 487-97.
33. Ali HF. Evaluation of antioxidants effect of Citrus reticulate in Schistosoma mansoni infected mice. Trends Med Res 2007; 2: 37- 43.
34. El-Sokkary GH, Omar HM, Hassanein AF, Cuzzocrea S, Reiter RJ. Melatonin reduces oxidative damage and increases survival of mice infected with Schistosoma mansoni. Free Rad Biol Med 2002; 32: 319-32.
35. Bin Dajem SM, Ibrahim EH, Al-Quraishy S., Mostafa OM. Fingerprint of Biomphalaria arabica, the intermediate host of Schistosoma mansoni in Saudi Arabia, using RAPD-PCR. Gene 2011; 485: 69-72.
36. Hussein MSh, El-Tawil OS, Nour HY, Abdou K. The Protective Effect of Morus alba and Calendula officinalis Plant Extracts on Carbon Tetrachloride- Induced Hepatotoxicity in Isolated Rat Hepatocytes. J Am Sci 2010; 6(10): 762-73.
37. Hamdy SM. Effect of Morus Alba Linn extract on Enzymatic Activities in Diabetic Rats. J App Sci Res 2012; 8(1): 10-16.
38. Madhumitha S, Indhuleka A. Cardioprotective Effect of Morus Alba L. Leaves in Isoprenaline Induced Rats. IJPSR 2012; 3(5): 1475-80.
39. Amer OS, Dkhil MA, Al-Quraishy S. Antischistosomal and hepatoprotective activity of Morus alba leaves extract. Pak J Zool 2013; 45: 387-93.
40. Nade VS, Kawale LA, Bhangale SP, Wale YB. Cardioprotective and Antihypertensive Potential of Morus alba L. in Isoproterenolinduced Myocardial Infarction and Renal Artery Ligation-induced Hypertension. J Nat Remed 2013; 13(1): 54-67.
41. El-Beshbishy HA, Singab AN, Sinkkonen J, Pihlaja K. Hypolipidemic and antioxidant effects of Morus alba L. (Egyptianmulberry) root bark fractions supplementation in cholesterol-fed rats. Life Sci 2006; 78(23): 2724-33.
42. Chen JJ, Li XG. Hypolipidemic effect of flavonoids from mulberry leaves in triton WR-1339 induced hyperlipidemic mice. Asia Pac J Clin Nutr 2007; 16: 290-4.
43. Iqbal S, Younas U, Sirajuddin Chan KW, Sarfraz RA, Uddin K. Proximate Composition and Antioxidant Potential of Leaves from Three Varieties of Mulberry (Morus sp.): A Comparative Study. Int J Mol Sci 2012; 13(6): 6651-64.
44. Bauomy AA, Diab MSM, Abdel Moneim AE, Dkhil MA, Al- Quraishy S. Neuronal activities of berberine in Schistosoma mansoni-infected mice. Afr J Pharm Pharmacol 2013; 7(7): 368-74.
45. Johnston GAR. GABAA Receptor Channel Pharmacology. Curr Pharm Des 2005; 11: 1867-85.
46. Streeter CC, Whitfield TH, Owen L, et al. Effects of Yoga Versus Walking on Mood, Anxiety, and Brain GABA Levels: A Randomized Controlled MRS Study. J Altern Complement Med 2010; 16(11): 1145-52.
47. Kalueff A, Nutt DJ. Role of GABA in memory and anxiety. Depr Anxiety 1997; 4(3): 100-10.
48. Adeyemi OO, Yetmitan OK, Taiwo AE. Neurosedative and muscle relaxant activities of ethyl acetate extract of Baphia nitida AFZEL. J Ethnopharmacol 2006; 106: 312-6.
49. Priya S. Identification of acetylcholine esterase inhibitors from Morus alba L. leaves. J Nat Prod Plant Resour 2012; 2(3): 440-4.
50. Devi B, Sharma N, Kumar D, Jeet K. Morus Alba Linn.: A Phytopharmacological Review. Int J Pharm Pharmaceut Sci 2013; 5(Suppl 2): 14-8.
51. Siddiqui MF, Levey AI. Cholinergic therapies in Alzheimer’s disease. Drugs Fut 1999; 24: 417-44.
52. Stretch RGA, Leytham GWH, Kershaw WE. The effect of acute schistosomiasis upon learning in rats under different levels of motivation. Ann Trop Med Parasitol 1960; 54: 487-92.
53. Kvalsvig JD. The effect of parasitic infection on cognitive performance. Parasitol Today 1988; 4: 206-8.
54. Kavaliers M, Colwell DD, Choleris E. Parasites and behavior: an ethopharmacological analysis and biomedical implications. Neurosci Biobehav Rev 1999; 3: 1037-45.
55. Kavaliers M, Colwell DD, Choleris E. Parasites and behaviour: an ethopharmacological perspective. Parasitol Today 2000; 16: 464-8.
56. Howes MJ, Nicolette SLP, Houghton PJ. Plants with traditional uses and activities, relevant to the mangment of Alzheimer's disease and other cognitive disorders. Phytother Res 2003; 17: 1- 18.